Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban

Drug-induced lupus is an iatrogenic-induced autoimmune disease with common offending agents well documented in the literature. To our knowledge, there are no prior case reports of drug-induced lupus associated with apixaban or any other direct oral anticoagulant. We describe a case of drug-induced l...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, John, Lena, Steffi, Tarditi, Daniel, Banker, Gopika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896862/
https://www.ncbi.nlm.nih.gov/pubmed/33628568
http://dx.doi.org/10.1155/2021/8866761
_version_ 1783653627841216512
author Yang, John
Lena, Steffi
Tarditi, Daniel
Banker, Gopika
author_facet Yang, John
Lena, Steffi
Tarditi, Daniel
Banker, Gopika
author_sort Yang, John
collection PubMed
description Drug-induced lupus is an iatrogenic-induced autoimmune disease with common offending agents well documented in the literature. To our knowledge, there are no prior case reports of drug-induced lupus associated with apixaban or any other direct oral anticoagulant. We describe a case of drug-induced lupus with leukocytoclastic vasculitis associated with apixaban started 15 days prior, after a WATCHMAN procedure for atrial fibrillation in an 86-year-old male previously anticoagulated on rivaroxaban.
format Online
Article
Text
id pubmed-7896862
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-78968622021-02-23 Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban Yang, John Lena, Steffi Tarditi, Daniel Banker, Gopika Case Rep Rheumatol Case Report Drug-induced lupus is an iatrogenic-induced autoimmune disease with common offending agents well documented in the literature. To our knowledge, there are no prior case reports of drug-induced lupus associated with apixaban or any other direct oral anticoagulant. We describe a case of drug-induced lupus with leukocytoclastic vasculitis associated with apixaban started 15 days prior, after a WATCHMAN procedure for atrial fibrillation in an 86-year-old male previously anticoagulated on rivaroxaban. Hindawi 2021-02-13 /pmc/articles/PMC7896862/ /pubmed/33628568 http://dx.doi.org/10.1155/2021/8866761 Text en Copyright © 2021 John Yang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yang, John
Lena, Steffi
Tarditi, Daniel
Banker, Gopika
Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban
title Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban
title_full Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban
title_fullStr Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban
title_full_unstemmed Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban
title_short Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban
title_sort drug-induced lupus with leukocytoclastic vasculitis associated with apixaban
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896862/
https://www.ncbi.nlm.nih.gov/pubmed/33628568
http://dx.doi.org/10.1155/2021/8866761
work_keys_str_mv AT yangjohn druginducedlupuswithleukocytoclasticvasculitisassociatedwithapixaban
AT lenasteffi druginducedlupuswithleukocytoclasticvasculitisassociatedwithapixaban
AT tarditidaniel druginducedlupuswithleukocytoclasticvasculitisassociatedwithapixaban
AT bankergopika druginducedlupuswithleukocytoclasticvasculitisassociatedwithapixaban

Ejemplares similares